The Universities of Oxford, Cambridge and Southampton and GlaxoSmithKline partner to offer this new award. These PhD projects aim to address fundamental issues in drug failure rate and time to adoption. Our goals are more productive research and development with direct patient and public health impact.
The University of Southampton will be recruiting students to start in year two of the programme, with entry in September 2027. Applicants will need to apply directly to Oxford University.
For further information about the IDLA and how to apply, please visit the GSK-TTPS Industrial Doctoral Landscape Award website.
Mark Cragg
Professor of Experimental Cancer Biology
The University of Southampton is delighted to be part of such an exciting new programme, bringing pharma and academia together to develop the next generation of researchers with the skills to accelerate drug development and provide new medicines.